NATURE BIOTECHNOLOGY
Scope & Guideline
Leading the Charge in Biotechnological Excellence
Introduction
Aims and Scopes
- Genome Editing and Engineering:
A central theme in the journal is the exploration and advancement of genome editing technologies, particularly CRISPR and its derivatives. This includes the development of novel editing systems that enhance specificity and reduce off-target effects. - Synthetic Biology:
Nature Biotechnology publishes studies on synthetic biology, which involves designing and constructing new biological parts, devices, and systems. This encompasses the engineering of microbes for applications in medicine, agriculture, and environmental sustainability. - Biotherapeutics and Drug Development:
The journal frequently features research on the development of biotherapeutics, including monoclonal antibodies, CAR-T therapies, and RNA-based therapeutics. This area focuses on the translation of basic research into clinical applications. - Bioinformatics and Computational Biology:
Computational approaches to analyzing biological data are a major focus, with studies leveraging machine learning, deep learning, and other computational tools to interpret complex biological datasets. - Microbiome Research:
Research on the microbiome and its implications for health and disease is increasingly prominent, reflecting a growing interest in understanding host-microbe interactions and their therapeutic potential. - Regenerative Medicine and Stem Cell Technology:
The journal covers advancements in regenerative medicine, including the use of stem cells for tissue engineering and the development of new therapies for degenerative diseases.
Trending and Emerging
- Advanced Genome Editing Techniques:
Newly developed genome editing tools, such as prime editing and base editing, are gaining traction. These methods promise greater precision and fewer off-target effects, driving interest in their applications across various fields. - Integration of AI in Biotechnology:
The application of artificial intelligence and machine learning in biotechnology is rapidly expanding. Researchers are leveraging these technologies for predictive modeling, data analysis, and optimizing biotechnological processes. - Personalized Medicine:
Research focused on personalized medicine, particularly in the context of cancer and rare diseases, is on the rise. This trend is driven by advancements in genomics and an increasing emphasis on tailored therapeutic approaches. - Sustainability and Environmental Biotechnology:
There is an emerging focus on biotechnological solutions aimed at addressing environmental challenges, such as bioremediation and sustainable agricultural practices, reflecting a broader societal push towards sustainability. - Cell and Gene Therapies:
The field of cell and gene therapies is rapidly advancing, with increasing numbers of studies exploring novel therapies and delivery methods, particularly in the context of genetic disorders and cancer treatment.
Declining or Waning
- Traditional Drug Discovery Methods:
As biotechnology evolves, traditional methods of drug discovery, which rely heavily on high-throughput screening of small molecules, are becoming less prominent. The focus has shifted towards more innovative approaches, such as utilizing AI and machine learning for drug development. - Plant Biotechnology:
Although still relevant, the frequency of publications specifically focused on plant biotechnology has decreased as the field expands into more integrated approaches combining multiple disciplines such as synthetic biology and gene editing. - Animal Models in Drug Testing:
There appears to be a decline in studies centered around traditional animal models for drug testing, as researchers increasingly explore alternative methods, including organoids and in vitro systems that better mimic human physiology. - Single-Cell Genomics:
While single-cell genomics remains important, there is a noticeable shift towards more integrative approaches that combine single-cell data with spatial transcriptomics and proteomics, indicating a transition away from isolated single-cell studies.
Similar Journals
Biotechnology Journal
Fostering a community of innovators in biotechnology.Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.
Biotechnology and Genetic Engineering Reviews
Reviewing Breakthroughs in Genetic Engineering and Biotech.Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.
Research Journal of Biotechnology
Pioneering research for a sustainable biotechnological future.Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.
Cell Journal
Bridging Disciplines in Cell and Molecular BiologyCell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.
BIOTECHNOLOGY AND BIOENGINEERING
Shaping Tomorrow's Biotechnological BreakthroughsBIOTECHNOLOGY AND BIOENGINEERING, published by Wiley, is a leading journal in the domains of applied microbiology, biotechnology, and bioengineering. With an ISSN of 0006-3592 and E-ISSN of 1097-0290, this journal has established itself as an essential resource for researchers, professionals, and students aiming to advance their knowledge and stay updated on cutting-edge innovations and methodologies in biotechnology. The journal has a commendable impact factor, and it is ranked in the second quartile (Q2) across multiple categories for 2023. This positions it favorably among its peers, underscoring its significance in the scientific community; for example, it ranks 23rd out of 127 in the field of Applied Microbiology and Biotechnology. As a hub of critical research findings and technological advancements, BIOTECHNOLOGY AND BIOENGINEERING invites contributions that push the boundaries of biotechnological applications, fostering a deeper understanding and development of sustainable solutions to current global challenges.
Bioengineering-Basel
Unlocking Potential in Bioengineering ResearchBioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.
BIOTECHNOLOGY PROGRESS
Advancing the Frontiers of Biotechnology ResearchBIOTECHNOLOGY PROGRESS, a prominent journal published by Wiley, stands at the forefront of the biotechnology field, delivering cutting-edge research and emerging trends since its inception in 1985. With an ISSN of 8756-7938 and an E-ISSN of 1520-6033, this journal has carved out a significant niche within the academic community, reflected in its Q2 ranking within the Biotechnology category for 2023. Maintaining a strong presence in the Scopus database, it ranks #111 out of 311 in the categories of Biochemistry, Genetics, and Molecular Biology, demonstrating its commitment to quality and significance in the field. Although it does not offer open access, it remains accessible through various institutional subscriptions, ensuring that vital biological and biotechnological discoveries reach a broad audience, including researchers, professionals, and students. Given its rigorous peer-review process and a focus on innovative methodologies, BIOTECHNOLOGY PROGRESS is an indispensable resource for anyone looking to stay informed about the latest advancements and applications in biotechnology.
BioImpacts
Navigating contemporary challenges through cutting-edge studies.BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.
Journal of Biological Engineering
Advancing the Frontiers of Biological EngineeringJournal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.
AIMS Bioengineering
Unlocking Potential in Biomaterials and BeyondAIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.